Citation: Mj. Eppihimer et Rg. Schaub, Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules, MICROCIRCUL, 8(1), 2001, pp. 15-24
Authors:
Opal, SM
Sypek, JP
Keith, JC
Schaub, RG
Palardy, JE
Parejo, NA
Citation: Sm. Opal et al., Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection, SHOCK, 15(4), 2001, pp. 285-290
Authors:
Russell, KE
Read, MS
Bellinger, DA
Leitermann, K
Rup, BJ
McCarthy, KP
Keith, JC
Khor, SP
Schaub, RG
Nichols, TC
Citation: Ke. Russell et al., Intratracheal administration of recombinant human factor IX (BeneFix (TM))achieves therapeutic levels in hemophilia B dogs, THROMB HAEM, 85(3), 2001, pp. 445-449
Authors:
Denis, CV
Kwack, K
Saffaripour, S
Maganti, S
Andre, P
Schaub, RG
Wagner, DD
Citation: Cv. Denis et al., Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models, BLOOD, 97(2), 2001, pp. 465-472
Citation: A. Kumar et Rg. Schaub, Adjunctive therapies for enhancing the effect of currently available thrombolytic agents, DRUG FUTURE, 25(8), 2000, pp. 815-821
Authors:
Kumar, A
Villani, MP
Patel, UK
Keith, JC
Schaub, RG
Citation: A. Kumar et al., Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model, CIRCULATION, 99(10), 1999, pp. 1363-1369
Authors:
Dunussi-Joannopoulos, K
Runyon, K
Erickson, J
Schaub, RG
Hawley, RG
Leonard, JP
Citation: K. Dunussi-joannopoulos et al., Vaccines with interleukin-12-transduced acute myeloid leukemia cells elicit very potent therapeutic and long-lasting protective immunity, BLOOD, 94(12), 1999, pp. 4263-4273